Ceapro Inc
XTSX:CZO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tansun Technology Co Ltd
SZSE:300872
|
CN |
Ceapro Inc
Cash from Operating Activities
Ceapro Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ceapro Inc
XTSX:CZO
|
Cash from Operating Activities
-CA$3.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Burcon NutraScience Corp
TSX:BU
|
Cash from Operating Activities
-CA$7.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
|
EcoSynthetix Inc
TSX:ECO
|
Cash from Operating Activities
-$23.6k
|
CAGR 3-Years
83%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
42%
|
|
|
5N Plus Inc
TSX:VNP
|
Cash from Operating Activities
$67.4m
|
CAGR 3-Years
42%
|
CAGR 5-Years
13%
|
CAGR 10-Years
1%
|
|
|
Nano One Materials Corp
TSX:NANO
|
Cash from Operating Activities
-CA$12.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-23%
|
|
|
Neo Performance Materials Inc
TSX:NEO
|
Cash from Operating Activities
-$54m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ceapro Inc
Glance View
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
See Also
What is Ceapro Inc's Cash from Operating Activities?
Cash from Operating Activities
-3.6m
CAD
Based on the financial report for Dec 31, 2023, Ceapro Inc's Cash from Operating Activities amounts to -3.6m CAD.
What is Ceapro Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-11%
